共 125 条
- [81] Else M(1995)Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia J Clin Oncol 13 989-995
- [82] Savoie L(1995)Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study J Clin Oncol 13 974-982
- [83] Johnston JB(2003)Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia Blood 102 810-813
- [84] Allsup DJ(2003)Rituximab in relapsed or refractory hairy cell leukemia Blood 102 3906-3911
- [85] Cawley JC(2004)Rituximab as treatment for minimal residual disease in hairy cell leukaemia Eur J Haematol 73 412-417
- [86] Matutes E(2003)CD52 expression in hairy cell leukemia Am J Hematol 74 227-230
- [87] Tallman MS(2004)Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment Hematol J 5 451-452
- [88] Sansville JE(1999)Responses in refractory hairy cell leukemia to a recombinant immunotoxin Blood 94 3340-3348
- [89] Ravandi F(2000)Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies J Clin Oncol 18 1622-1636
- [90] Wheaton S(2003)Hairy-cell leukaemia as a model for drug development Best Pract Res Clin Haematol 16 83-89